Evidence map›Paper›PMID 30677147›Full record

ArticleMuscle & nerve2019

The myotonic dystrophy experience: a North American cross-sectional study.

Katharine A Hagerman, Sarah J Howe, Chad R Heatwole, Christopher Project Reference Group

Abstract read
In one paragraph

Article in Muscle & nerve, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Myotonic dystrophy family registry. The patient experience.Journal of neuromuscular diseases · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katharine A HagermanDepartment of Neurology, Stanford University, 1201 Welch Road, MSLS Room P220, Stanford, California, 94305, USA.
Sarah J HoweMarigold Foundation, Calgary, Alberta, Canada.
Chad R HeatwoleDepartment of Neurology, University of Rochester Medical Center, Rochester, New York, USA.
Christopher Project Reference Group

Funding

Marigold Foundation
6 · The paper itself

Abstract

introductionMyotonic dystrophy (DM) is a chronic, multisystemic, neurological condition. Patients and caregivers are uniquely suited to identify what symptoms are most important and highlight the unmet needs that are most relevant to DM.

methodsWe conducted a North American, cross-sectional study of people with DM type-1, congenital DM, and DM type-2 and their family members. We sent patients and caregivers separate surveys to identify and quantitate the issues of greatest importance, examine the differences between groups, and identify the most important challenges experienced by this population.

results1,180 people with DM and 402 family members/caregivers responded to the surveys. They reported considerable physical and cognitive symptoms, extensive diagnostic delays, and varying clinical phenotypes on the basis of DM type. DISCUSSION: Marked disease burden and numerous unmet needs exist in DM. These needs vary based on DM type and highlight the complex clinical phenotypes of these neurological disorders. Muscle Nerve 59:457-464, 2019.

Indexed as

Activities of Daily LivingAdolescentAdultCaregiversCognition DisordersCost of IllnessCross-Sectional StudiesDelayed DiagnosisEmploymentFamilyFemaleHumansIncomeMaleMiddle AgedMyotonic Dystrophycaregivermyotonic dystrophyneuromuscular diseasepatient reportunmet needs

Identifiers

PMID30677147
PMCPMC6590656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.